EMPA 25 mg contains Empagliflozin 25 mg. It is an oral antidiabetic medicine belonging to the SGLT2 inhibitor class, used to lower blood glucose levels in patients with type 2 diabetes by increasing glucose removal through urine.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps improve blood sugar control along with diet and exercise
-
Reduces the risk of cardiovascular complications in appropriate patients with type 2 diabetes
-
Helps reduce the risk of hospitalization due to heart failure in certain patients
-
May help protect kidney function in some patients with chronic kidney disease associated with diabetes (as prescribed)
Dose:
-
Adults: Usually 10 mg once daily initially, which may be increased to 25 mg once daily as directed by a physician
-
Take the medicine with or without food
-
Maintain adequate hydration unless fluid intake is restricted by a doctor
-
Dose may be adjusted according to blood glucose control and kidney function
-
Do not stop or change the dose without medical advice